Literature DB >> 22752716

Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study.

Edward Clark1, Ron Wald, Adeera Levin, Josée Bouchard, Neill K J Adhikari, Michelle Hladunewich, Robert M A Richardson, Matthew T James, Michael W Walsh, Andrew A House, Louise Moist, Daniel E Stollery, Karen E A Burns, Jan O Friedrich, James Barton, Jean-Philippe Lafrance, Neesh Pannu, Sean M Bagshaw.   

Abstract

PURPOSE: The optimal timing for starting renal replacement therapy (RRT) in patients with acute kidney injury (AKI) is unknown. Defining current practice is necessary to design interventional trials. We describe the current Canadian practice regarding the timing of RRT initiation for AKI.
METHODS: An observational study of patients undergoing RRT for AKI was undertaken at 11 intensive care units (ICUs) across Canada. Data were captured on demographics, clinical and laboratory findings, indications for RRT, and timing of RRT initiation.
RESULTS: Among 119 consecutive patients, the most common ICU admission diagnosis was sepsis/septic shock, occurring in 54%. At the time of RRT initiation, the median and interquartile range (IQR) serum creatinine level was 322 (221-432) μmol·L(-1). The mean (SD) values for other parameters were as follows: Sequential Organ Failure Assessment (SOFA) score 13.4 (4.1), pH 7.25 (0.15), potassium 4.6 (1.0) mmol·L(-1). Also, 64% fulfilled the serum creatinine-based criterion for Acute Kidney Injury Network (AKIN) stage 3. Severity of illness, measured using Acute Physiology and Chronic Health Evaluation (APACHE II) and SOFA scores, did not correlate with AKI severity as defined by the serum creatinine-based AKIN criteria. Median (IQR) time from hospital and ICU admission to the start of RRT was 2.0 (1.0-7.0) days and 1.0 (0-2.0) day, respectively.
CONCLUSION: Patients admitted to an ICU who were started on RRT generally had advanced AKI, high-grade illness severity, and multiorgan dysfunction. Also, they were started on RRT shortly after hospital presentation. We describe the current state of practice in Canada regarding the initiation of RRT for AKI in critically ill patients, which can inform the designs of future interventional trials.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752716     DOI: 10.1007/s12630-012-9750-4

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

1.  Dialysis versus nondialysis in patients with AKI: a propensity-matched cohort study.

Authors:  F Perry Wilson; Wei Yang; Carlos A Machado; Laura H Mariani; Yuliya Borovskiy; Jeffrey S Berns; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

2.  Selection and Receipt of Kidney Replacement in Critically Ill Older Patients with AKI.

Authors:  Sean M Bagshaw; Neill K J Adhikari; Karen E A Burns; Jan O Friedrich; Josée Bouchard; Francois Lamontagne; Lauralyn A McIntrye; Jean-François Cailhier; Peter Dodek; Henry T Stelfox; Margaret Herridge; Stephen Lapinsky; John Muscedere; James Barton; Donald Griesdale; Mark Soth; Althea Ambosta; Gerald Lebovic; Ron Wald
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-21       Impact factor: 8.237

3.  Which patients benefit from initiation of dialysis for AKI?

Authors:  Neesh Pannu
Journal:  Clin J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 8.237

4.  Combined Therapy With Adipose-Derived Mesenchymal Stem Cells and Ciprofloxacin Against Acute Urogenital Organ Damage in Rat Sepsis Syndrome Induced by Intrapelvic Injection of Cecal Bacteria.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Chih-Hung Chen; Yi-Ling Chen; Tien-Hung Huang; Yen-Yi Zhen; Meng-Wei Chang; Chu-Feng Liu; Sheng-Ying Chung; Yung-Lung Chen; Han-Tan Chai; Cheuk-Kwan Sun; Hon-Kan Yip
Journal:  Stem Cells Transl Med       Date:  2016-04-13       Impact factor: 6.940

Review 5.  Current practice of conventional intermittent hemodialysis for acute kidney injury.

Authors:  H Schiffl; S M Lang
Journal:  Indian J Nephrol       Date:  2013-11

6.  Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats.

Authors:  Pei-Hsun Sung; Chia-Lo Chang; Tzu-Hsien Tsai; Li-Teh Chang; Steve Leu; Yung-Lung Chen; Chic-Chao Yang; Sarah Chua; Kuo-Ho Yeh; Han-Tan Chai; Hsueh-Wen Chang; Hong-Hwa Chen; Hon-Kan Yip
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

7.  Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial.

Authors:  Orla M Smith; Ron Wald; Neill K J Adhikari; Karen Pope; Matthew A Weir; Sean M Bagshaw
Journal:  Trials       Date:  2013-10-05       Impact factor: 2.279

8.  Impact on mortality of the timing of renal replacement therapy in patients with severe acute kidney injury in septic shock: the IDEAL-ICU study (initiation of dialysis early versus delayed in the intensive care unit): study protocol for a randomized controlled trial.

Authors:  Saber Davide Barbar; Christine Binquet; Mehran Monchi; Rémi Bruyère; Jean-Pierre Quenot
Journal:  Trials       Date:  2014-07-07       Impact factor: 2.279

9.  Importance of RIFLE (Risk, Injury, Failure, Loss, and End-Stage Renal Failure) and AKIN (Acute Kidney Injury Network) in Hemodialysis Initiation and Intensive Care Unit Mortality.

Authors:  Iskender Kara; Fatma Yildirim; Esra Kayacan; Burcu Bilaloğlu; Melda Turkoglu; Gülbin Aygencel
Journal:  Iran J Med Sci       Date:  2017-07

10.  Prevalence of Laboratory Critical Results in Eye Patients from an Eye Hospital in Southern China.

Authors:  Fang Duan; Jingyu Liao; Liping Lin; Xiuping Liu; Kaili Wu
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.